Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
1,148
Sort by:
dPCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
US$ 4,450.00
According to our new research study on “dPCR Market Forecast to 2031 –Global Analysis – by Product, Application, and End User,” the market is anticipated to grow from US$7.52 billion in 2024 to US$14....
January 2026
269 pages
RT-PCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
US$ 4,450.00
According to our new research study on “RT-PCR Market Forecast to 2031 –Global Analysis – by Product, Application, and End User,” the market is anticipated to grow from US$2.71 billion in 2024 to US$4...
January 2026
274 pages
Epigenetic Diagnostics Market - Forecast from 2026 to 2031
US$ 3,950.00
The Epigenetic Diagnostics Market is projected to grow significantly during the forecast period (2026-2031). The Epigenetic Diagnostics market is emerging as a transformative segment within molecular...
January 2026
148 pages
Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, Circulating Nucleic Acids, CTC), By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global liquid biopsy market size is expected to reach USD 5.96 billion by 2030, according to a new report by Grand ... period. Enhanced view of tumor provided by liquid biopsy technology is estimated to augment the market in coming years. While tissue biopsies have been standard for cancer ...
January 2026
150 pages
North America Liquid Biopsy Market - 2023-2031
US$ 2,999.00
The North America Liquid Biopsy Market was valued at US$ 1464.00 million in 2023 and is anticipated to reach US$ 5110.34 million by 2031, at a CAGR of 0.171 from 2026 to 2032. The report delivers in-d...
January 2026
207 pages
The 2027-2032 World Outlook for Molecular Diagnostics
US$ 1,195.00
This study covers the world outlook for molecular diagnostics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
January 2026
287 pages
The 2027-2032 World Outlook for Nucleic Acid Testing
US$ 1,195.00
This study covers the world outlook for nucleic acid testing across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for nucleic acid testing. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Molecular Diagnostics (MDx)
US$ 1,195.00
This study covers the world outlook for molecular diagnostics (MDx) across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for molecular diagnostics (MDx). It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for Quantitative Polymerase Chain Reaction (qPCR) Reagents
US$ 1,195.00
This study covers the world outlook for quantitative polymerase chain reaction (qPCR) reagents across more than 190 countries. ... or the P.I.E., for quantitative polymerase chain reaction (qPCR) reagents. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, ...
January 2026
307 pages
The 2027-2032 World Outlook for In-Vitro Colorectal Cancer Screening Tests
US$ 1,195.00
This study covers the world outlook for in-vitro colorectal cancer screening tests across more than 190 countries. For each year ... demand, or the P.I.E., for in-vitro colorectal cancer screening tests. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
291 pages
